XML 22 R2.htm IDEA: XBRL DOCUMENT v3.24.4
BALANCE SHEETS - USD ($)
Sep. 30, 2024
Sep. 30, 2023
Current assets:    
Cash and cash equivalents $ 4,738,173 $ 4,145,735
Prepaid expenses 294,097 520,368
Supplies used for R&D and manufacturing 1,019,908 2,248,072
Deposits 3,500 4,245
Total current assets 6,055,678 6,918,420
Finance lease right-of-use assets 7,350,364 9,131,987
Operating lease right-of-use assets 1,495,937 1,698,243
Property and equipment, net 8,129,753 10,188,126
Patent costs, net 165,492 197,704
Deposits 2,319,101 2,319,101
Supplies used for R&D and manufacturing 1,475,441 74,669
Total assets 26,991,766 30,528,250
Current Liabilities:    
Accounts payable 1,448,467 2,009,786
Accrued expenses 566,042 1,049,581
Due to employees 363,306 557,244
Finance lease obligation, current portion 2,010,995 1,771,804
Operating lease obligation, current portion 226,969 197,431
Total current liabilities 4,615,779 5,585,846
Finance lease liabilities, net of current portion 7,957,925 9,949,565
Operating lease liabilities, net of current portion 1,425,979 1,652,949
Other liabilities 125,000 125,000
Total liabilities 14,124,683 17,313,360
STOCKHOLDERS' EQUITY    
Preferred stock, $0.01 par value; 200,000 shares authorized; 0 shares issued and outstanding 0 0
Common stock, $0.01 par value; 600,000,000 shares authorized; 63,787,104 and 47,422,304 shares issued and outstanding at September 30, 2024 and 2023, respectively 637,870 474,223
Additional paid-in capital 526,241,074 499,832,063
Accumulated deficit (514,011,861) (487,091,396)
Total stockholders' equity 12,867,083 13,214,890
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 26,991,766 $ 30,528,250